Agarwal R - Search Results

1

A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.

Flaig TW, Glodé M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su LJ, Li Y, Harrison G, Agarwal R, Crawford ED, Lucia MS, Pollak M. Flaig TW, et al. Among authors: agarwal r. Prostate. 2010 Jun 1;70(8):848-55. doi: 10.1002/pros.21118. Prostate. 2010. PMID: 20127732 Clinical Trial.

2

Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.

Zi X, Zhang J, Agarwal R, Pollak M. Zi X, et al. Among authors: agarwal r. Cancer Res. 2000 Oct 15;60(20):5617-20. Cancer Res. 2000. PMID: 11059749

3

Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells.

Bhatia N, Agarwal R. Bhatia N, et al. Among authors: agarwal r. Prostate. 2001 Feb 1;46(2):98-107. doi: 10.1002/1097-0045(20010201)46:2<98::aid-pros1013>3.0.co;2-k. Prostate. 2001. PMID: 11170137

4

Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.

Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Tyagi A, et al. Among authors: agarwal c, agarwal r. Prostate. 2002 Nov 1;53(3):211-7. doi: 10.1002/pros.10146. Prostate. 2002. PMID: 12386921

5

Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line.

Qi L, Singh RP, Lu Y, Agarwal R, Harrison GS, Franzusoff A, Glode LM. Qi L, et al. Among authors: agarwal r. Cancer Biol Ther. 2003 Sep-Oct;2(5):526-31. doi: 10.4161/cbt.2.5.452. Cancer Biol Ther. 2003. PMID: 14614320 Free article.

6

Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.

Tyagi A, Agarwal C, Harrison G, Glode LM, Agarwal R. Tyagi A, et al. Among authors: agarwal c, agarwal r. Carcinogenesis. 2004 Sep;25(9):1711-20. doi: 10.1093/carcin/bgh180. Epub 2004 Apr 29. Carcinogenesis. 2004. PMID: 15117815

7

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.

Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glodé LM. Flaig TW, et al. Among authors: agarwal r. Invest New Drugs. 2007 Apr;25(2):139-46. doi: 10.1007/s10637-006-9019-2. Epub 2006 Nov 1. Invest New Drugs. 2007. PMID: 17077998 Clinical Trial.

8

Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.

Flaig TW, Su LJ, Harrison G, Agarwal R, Glodé LM. Flaig TW, et al. Among authors: agarwal r. Int J Cancer. 2007 May 1;120(9):2028-33. doi: 10.1002/ijc.22465. Int J Cancer. 2007. PMID: 17230508

9

Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.

Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R. Singh RP, et al. Among authors: agarwal r. Carcinogenesis. 2007 Dec;28(12):2567-74. doi: 10.1093/carcin/bgm218. Epub 2007 Oct 4. Carcinogenesis. 2007. PMID: 17916909

10

Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.

Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R. Raina K, et al. Among authors: agarwal r. Cancer Res. 2007 Nov 15;67(22):11083-91. doi: 10.1158/0008-5472.CAN-07-2222. Cancer Res. 2007. PMID: 18006855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,257 results

Search Page

Filters